GCA
ELAN icon

Greenwood Capital Associates’s Elanco Animal Health ELAN Stock Holding History

Greenwood Capital Associates’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,800
Closed -$253K – 187
2020
Q2 		$253K Sell
11,800
-13,065
-53% -$289K 0.06% 159
2020
Q1 		$557K Buy
24,865
+2,375
+11% +$65.1K 0.16% 73
2019
Q4 		$662K Buy
22,490
+3,090
+16% +$84K 0.14% 95
2019
Q3 		$516K Buy
19,400
+3,155
+19% +$94.7K 0.13% 94
2019
Q2 		$549K Buy
16,245
+7,155
+79% +$232K 0.14% 92
2019
Q1 		$292K Buy
+9,090
New +$280K 0.08% 136

Other funds holding ELAN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Greenwood Capital Associates's ELAN Position: Q3 2020 in Review

Greenwood Capital Associates sold out of Elanco Animal Health (ELAN) in Q3 2020, closing a stake of 11,800 shares — an estimated $253K sold.

Greenwood Capital Associates first reported a position in ELAN in Q1 2019 and held it in 6 quarters. The position peaked at $662K in Q4 2019. 361 funds tracked by Wall St. Rank hold ELAN as of Q3 2020.

  • Greenwood Capital Associates reported no remaining Elanco Animal Health position as of Q3 2020 after selling out during the quarter.
  • Greenwood Capital Associates sold 11,800 Elanco Animal Health shares in Q3 2020, an estimated $253K.
  • Greenwood Capital Associates first reported a position in Elanco Animal Health in Q1 2019 and held it in 6 quarters.
  • Greenwood Capital Associates's Elanco Animal Health position peaked at $662K in Q4 2019.
  • 361 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2020.

Based on Greenwood Capital Associates's 13F filing for Q3 2020, filed 12 Nov 2020.